Performance analysis of GreenLight Biosciences (GRNA)
Annual Return
Over the past 3 years, GRNA has had an average annual return of +0%, outperforming the benchmark SPY, which returned -1.34% annual.
Since Feb 3, 2022, GRNA has had an average annual return of -89.54%, underperforming the benchmark SPY, which returned +1.79% annual.
| 2023 | 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -74.60% | -87.44% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -7.64% | -55.95% | -9.98% | -26.30% | -8.26% | +1.93% | +0.63% | +0% | -74.60% | ||||
| 2022 | -32.97% | +52.86% | -15.36% | -9.33% | -70.10% | -4.04% | +33.95% | -18.33% | -23.26% | -16.84% | -20.25% | -87.44% |
Drawdown analysis of GreenLight Biosciences (GRNA)
The maximum drawdown for the GRNA was -98.70%, occurring on May 24, 2023. This drawdown has not yet recovered.
The current GRNA drawdown is -97.79%.
Since Feb 3, 2022 GRNA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.70% | Mar 21, 2022 | 296 | May 24, 2023 | Ongoing | Ongoing | Ongoing |
| -47.65% | Feb 3, 2022 | 20 | Mar 4, 2022 | 4 | Mar 10, 2022 | 24 |
| -11.72% | Mar 11, 2022 | 1 | Mar 14, 2022 | 1 | Mar 15, 2022 | 2 |
| -0.30% | Mar 15, 2022 | 1 | Mar 16, 2022 | 1 | Mar 17, 2022 | 2 |